Association of insulin resistance and nocturnal fall of blood pressure in GH-deficient adults during GH replacement

被引:0
|
作者
R. Resende Lima Oliveira de Brasil
D. Vieira Soares
L. Diniz Carneiro Spina
P. Marise Lobo
E. Maria Carvalho da Silva
V. Mansur Aleta
M. F. Miguens Castelar Pinheiro
F. L. Conceição
M. Vaisman
机构
[1] Federal University of Rio de Janeiro (UFRJ),Service of Endocrinology, Clementino Fraga Filho University Hospital, Medical School
[2] Previlab-Medical Services Ltda,undefined
[3] Medical Laboratory Sérgio Franco Diagnostic Medicine,undefined
关键词
Insulin resistance; blood pressure; ambulatory monitoring of blood pressure (AMBP); growth hormone; deficiency;
D O I
10.1007/BF03346297
中图分类号
学科分类号
摘要
The GH deficiency syndrome in adults is characterized by changes in body composition, metabolic, cardiovascular and psychological profile. Such alterations fit the metabolic syndrome. Changes of blood pressure (BP) levels related to the presence of insulin resistance (IR) may be present in the GH-deficient adult prior to or after therapy with recombinant GH (hGH). The purpose of the study was to assess the relationship between BP and IR in GH-deficient adults after 24 months of replacement with hGH. Thirteen GH-deficient adults were studied [7 men and 6 women, with an average age of 38.6±14.14 yr body mass index (BMI) 25.83±2.26 kg/m2]. The BP was assessed by means of ambulatory monitoring of BP (AMBP), prior to the treatment and 12 and 24 months after replacement with hGH. Glucose metabolism was assessed by the homeostatic model assessment (HOMA), during the same periods. The average dosage of hGH utilized was 0.67±0.15 mg/day. In the analysis of BP levels, we observed a decrease of the diurnal systolic BP (SBP) (p=0.043) and a reduction of the diurnal systolic (p=0.002) and diastolic pressure loads (p=0.038). During the night there were no changes in BP levels. We observed an increase in the percentage of patients with a non-physiological nocturnal fall (non dippers) after replacement with hGH (61.53%). The mean HOMA, insulin and glucose in the fasting state did not present any statistically significant changes. Although the patients within the non-dipper group had higher HOMA and insulin levels throughout the study, there were no changes in any of these parameters after GH replacement. All patients with HOMA >2.5 were within the non-dipper group, whereas all dippers had HOMA <2.5. In conclusion, 24 months of therapy with hGH do not seem to have affected glucose homeostasis, and since there is no relationship with the increase of the percentage of non-physiological nocturnal fall, we will need a longer observation time to discover the effects of this finding.
引用
收藏
页码:306 / 312
页数:6
相关论文
共 50 条
  • [1] Association of insulin resistance and nocturnal fall of blood pressure in GH-deficient adults during GH replacement
    de Lima Oliveira Brasil, R. Resende
    Soares, D. Vieira
    Carneiro Spina, L. Diniz
    Lobo, P. Marise
    Carvalho da Silva, E. Maria
    Aleta, V. Mansur
    Castelar Pinheiro, M. F. Miguens
    Conceicao, F. L.
    Vaisman, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2007, 30 (04) : 306 - 312
  • [2] Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults
    Svensson, J
    Fowelin, J
    Landin, K
    Bengtsson, BÅ
    Johansson, JO
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05): : 2121 - 2127
  • [3] GH replacement reduces increased lipid peroxidation in GH-deficient adults
    Karbownik-Lewinska, Malgorzata
    Kokoszko, Agnieszka
    Lewandowski, Krzysztof C.
    Shalet, Stephen M.
    Lewinski, Andrzej
    CLINICAL ENDOCRINOLOGY, 2008, 68 (06) : 957 - 964
  • [4] GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults
    Lanzi, R
    Losa, M
    Villa, I
    Gatti, E
    Sirtori, M
    Dal Fiume, C
    Rubinacci, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (02) : 185 - 191
  • [5] Overall and cause-specific mortality in GH-deficient adults on GH replacement
    Gaillard, Rolf C.
    Mattsson, Anders F.
    Akerblad, Ann-Charlotte
    Bengtsson, Bengt-Ake
    Cara, Jose
    Feldt-Rasmussen, Ulla
    Koltowska-Haeggstroem, Maria
    Monson, John P.
    Saller, Bernhard
    Wilton, Patrick
    Abs, Roger
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (06) : 1069 - 1077
  • [6] Growth Hormone (GH)-Induced Insulin Resistance Is Rapidly Reversible: An Experimental Study in GH-Deficient Adults
    Krusenstjerna-Hafstrom, T.
    Clasen, B. F.
    Moller, N.
    Jessen, N.
    Pedersen, S. B.
    Christiansen, J. S.
    Jorgensen, J. O. L.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (08): : 2548 - 2557
  • [7] GH-deficient survivors of childhood cancer: GH replacement during adult life
    Murray, RD
    Darzy, KH
    Gleeson, HK
    Shalet, SM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01): : 129 - 135
  • [8] Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy
    Wirén, L
    Boguszewski, CL
    Johannsson, G
    CLINICAL ENDOCRINOLOGY, 2002, 57 (02) : 235 - 239
  • [9] Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician
    Kevin C. J. Yuen
    Anthony P. Heaney
    Vera Popovic
    Endocrine, 2016, 52 : 194 - 205
  • [10] Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician
    Yuen, Kevin C. J.
    Heaney, Anthony P.
    Popovic, Vera
    ENDOCRINE, 2016, 52 (02) : 194 - 205